← Evidence map

ReviewHemaSphere2026

Triplet regimens for frontline treatment of CLL-Great company or just a crowd?

Sean McKeague et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41560849